Cell-penetrating
peptides (CPPs) have been widely used as vehicles
for delivering therapeutic molecules to the site of action. Apart
from their delivering potential, the biological effects of CPPs have
not been explored in detail. JTS-1 is a CPP that has been reported
to have gene delivery functions, although its biological role is yet
to be determined. Hence, in this study, we revealed the biological
mechanism such as its uptake mechanism and immunogenic potential and
function using primary human tenon fibroblast (TF) cells collected
from patients undergoing glaucoma trabeculectomy surgery. Our results
showed that the JTS-1 peptide has an α-helical structure and
is nontoxic up to 1 μM concentration. It was found to be colocalized
with early endosome (Rab5), recycling endosome (Rab7), and Rab11 and
interacted with major histocompatibility complex (MHC) class I and
II. The peptide also affected actin polymerization, which is regulated
by cofilin phosphorylation and ROCK1 localization. It also inhibited
TF cell proliferation. Therefore, the JTS-1 peptide could be used
as a possible therapeutic agent for modifying the fibrosis process,
where TF proliferation is a key cause of surgery failure.